Larvol Delta - ABVC-BioPharma-Executes-a-Global-Licensing-Term-Sheet-for-OncologyHematology-Products-Expecting-Licensing-Income-of-55M-and-Royalties-of-up-to-50M

RGC-1502 - ABVC BioPharma, Rgene Corp

ABV-1702 - ABVC BioPharma

RGC-1501 - ABVC BioPharma, Rgene Corp

ABV-1501 - ABVC BioPharma

https://www.globenewswire.com/news-release/2024/04/10/2860744/0/en/ABVC-BioPharma-Executes-a-Global-Licensing-Term-Sheet-for-Oncology-Hematology-Products-Expecting-Licensing-Income-of-55M-and-Royalties-of-up-to-50M.html

Apr 10, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next